284 related articles for article (PubMed ID: 28660155)
1. New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Yin J; Bo WT; Sun J; Xiang X; Lang JY; Zhong JH; Li LQ
J Clin Transl Hepatol; 2017 Jun; 5(2):169-176. PubMed ID: 28660155
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016.
Chan SL; Chong CC; Chan AW; Poon DM; Chok KS
World J Gastroenterol; 2016 Aug; 22(32):7289-300. PubMed ID: 27621575
[TBL] [Abstract][Full Text] [Related]
3. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.
Tao ZW; Cheng BQ; Zhou T; Gao YJ
Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):134-144. PubMed ID: 34955380
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
[TBL] [Abstract][Full Text] [Related]
6. The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus.
Luo F; Li M; Ding J; Zheng S
Front Oncol; 2021; 11():635731. PubMed ID: 34631513
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges.
Jiang JF; Lao YC; Yuan BH; Yin J; Liu X; Chen L; Zhong JH
Oncotarget; 2017 May; 8(20):33911-33921. PubMed ID: 28430610
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in treatment strategies for hepatocellular carcinoma with portal vein cancer thrombus.
Tan ZB; Zhang J
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8119-8134. PubMed ID: 37750640
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib--a retrospective controlled study.
Zhu K; Chen J; Lai L; Meng X; Zhou B; Huang W; Cai M; Shan H
Radiology; 2014 Jul; 272(1):284-93. PubMed ID: 24708192
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update.
Ye JZ; Wang YY; Bai T; Chen J; Xiang BD; Wu FX; Li LQ
Oncotarget; 2017 Nov; 8(54):93258-93278. PubMed ID: 29190996
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
Han K; Kim JH; Ko GY; Gwon DI; Sung KB
World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
[TBL] [Abstract][Full Text] [Related]
12. Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report.
Hidaka Y; Tomita M; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
World J Surg Oncol; 2022 Jul; 20(1):228. PubMed ID: 35831894
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ
BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010
[TBL] [Abstract][Full Text] [Related]
14. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
[TBL] [Abstract][Full Text] [Related]
15. The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
Zhang Y; Miao H; Xie W; Jiang S; Song Z; Huang G; Fan W; Wang Y; Li J; Chen Y
Eur Radiol; 2021 Jan; 31(1):232-243. PubMed ID: 32728770
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis.
Wang JC; Xia AL; Xu Y; Lu XJ
J Cell Physiol; 2019 Feb; 234(2):1062-1070. PubMed ID: 30256409
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
Li S; Li L; Li B; Wang W
Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068
[TBL] [Abstract][Full Text] [Related]
18. Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience.
Patidar Y; ; Mukund A; Sarin SK
Indian J Radiol Imaging; 2021 Apr; 31(2):270-276. PubMed ID: 34556907
[No Abstract] [Full Text] [Related]
19. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
20. Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
Liu PH; Huo TI; Miksad RA
Semin Liver Dis; 2018 Aug; 38(3):242-251. PubMed ID: 30041276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
